Patent · US Active

Materials and methods for treatment of pulmonary arterial hypertension

US9840705B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignee

The University Court of the University of Glasgow · GB

Inventors

Margaret MacLean · Glasgow, GB
Emma Wallace · Glasgow, GB
Andrew Baker · Glasgow, GB

Key dates

Filing date	Dec 1, 2014
Grant date	Dec 12, 2017
Priority date	—
Expiry date	Dec 1, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2740/15041
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention relates to the use of microRNA 96 and precursors and mimics thereof for the inhibition of vascular cell proliferation and/or vascular remodelling, and for the treatment of associated medical conditions such as pulmonary arterial hypertension (PAH).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.